532 filings
Page 2 of 27
4
04k x2qg0ej
9 Feb 24
Syndax Pharmaceuticals / Michael A Metzger ownership change
4:05pm
4
qjs56jkv2g
9 Feb 24
Syndax Pharmaceuticals / Keith A. Goldan ownership change
4:05pm
4
pkexrhqqw
9 Feb 24
Syndax Pharmaceuticals / Neil Gallagher ownership change
4:05pm
4
wb84x
9 Feb 24
Syndax Pharmaceuticals / Martin H. Jr. Huber ownership change
4:04pm
4
cv3xpncq0 sj
9 Feb 24
Syndax Pharmaceuticals / Jennifer Jarrett ownership change
4:04pm
4
iwwo9y hj0f
9 Feb 24
Syndax Pharmaceuticals / Keith Katkin ownership change
4:04pm
4
hgx1gaw
9 Feb 24
Syndax Pharmaceuticals / William Meury ownership change
4:04pm
4
qrwxjgfi42lrj
9 Feb 24
Syndax Pharmaceuticals / Briggs Morrison ownership change
4:04pm
4
jr8h7r55
9 Feb 24
Syndax Pharmaceuticals / Dennis Podlesak ownership change
4:04pm
4
zg5h8fe0rj9wfen
9 Feb 24
Syndax Pharmaceuticals / Pierre Legault ownership change
4:04pm
SC 13G/A
5irkyl td
8 Feb 24
Syndax Pharmaceuticals / WELLINGTON MANAGEMENT ownership change
10:18am
SC 13G/A
oqit04bwrv9m
25 Jan 24
Syndax Pharmaceuticals / BlackRock ownership change
4:59pm
SC 13G/A
1ckrdsk opzss0
25 Jan 24
Syndax Pharmaceuticals / STATE STREET ownership change
11:20am
8-K
1r9w1uyt6yt1zz
20 Dec 23
Syndax Announces Closing of Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares
8:40am
8-K
2mbg nnrd
15 Dec 23
Entry into a Material Definitive Agreement
5:29pm
424B5
j6xh0jb2ilxstdgaor
15 Dec 23
Prospectus supplement for primary offering
5:29pm
424B5
v6tjzgwpfnnr yn6c1
14 Dec 23
Prospectus supplement for primary offering
4:30pm
8-K
8b0smvwcee4qaiiqiu01
12 Dec 23
Other Events
4:05pm
UPLOAD
gevbi4ju8c9oqu09
7 Dec 23
Letter from SEC
12:00am
CORRESP
d9fn2ho fa
28 Nov 23
Correspondence with SEC
12:00am